| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |